The EMA approved vaccines are Pfizer-BioNTech, Moderna, Johnson & Johnson, and the version of the Oxford-AstraZeneca vaccine manufactured in the UK or Europe, which is sold under the brand name Vaxzevria.
“Entry into the EU should be allowed to people fully vaccinated with one of the vaccines authorised in the EU,” a spokesperson from the European Commission said. “Member States are… not required to issue certificates for a vaccine that is not authorised on their territory.”
The UK authorities have used the brand name Vaxzevria on all UK medical records where the AstraZeneca vaccine has been used, but up to five million doses are actually the Indian-made Covishield version. The doses remain identifiable by their batch numbers.
“For these purposes, the batch numbers; 4120Z001, 4120Z002, 4120Z003 of the SIIPL COVID‑19 Vaccine (ChAdOx1‑S [recombinant]) manufactured by Serum Institute India… were assessed and are treated as Covid-19 Vaccine AstraZeneca,” says an amendment made to the agreement between AstraZeneca and the UK regulator, the Medicines and Healthcare products Regulatory Authority (MHRA), on February 23.
The EU vaccine passport will soon integrate with the Covid travel pass on the NHS app. By scanning a QR code, the EU system pulls up information including the traveller’s name, date of birth and vaccine details, including batch numbers.